Search

Scientists at UT Southwestern Medical Center, working with other U.S. researchers, have uncovered the structure of a key cell membrane protein in a bacterial model for Chlamydia trachomatis, the cause of the world’s most common bacterial sexually transmitted infection (STI).

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier stage kidney cancers in combination with an immunotherapy drug.

A team at UT Southwestern Medical Center is the first in North Texas to offer single-port robotic-assisted thoracoscopic lobectomy, a minimally invasive procedure for select patients with early-stage lung cancer.

A message from the chair of the Department of Dermatology.

Learn about The Discovery Engine Program in the Lyda Hill Department of Bioinformatics at UT Southwestern.

Basic Research Vice Provost Joan W. Conaway, Ph.D. Vice Provost, Dean of Basic Research, and Professor of Molecular Biology Holder of the Cecil H. Green Distinguished Chair in Cellular and Molecular Biology Associate Deans Deborah Carlson, Ph.D. Assistant Dean, Research Support Facilities Assistant P…

Learn more about the Chair of the Department of Surgery at UT Southwestern.

Meet our Clinical Pastoral Education Residents.

Clinical exams that incorporate gait analysis after physical exertion may provide insight into how youths are recovering after concussions to help determine whether they are ready to return to sports, UT Southwestern Medical Center and Scottish Rite for Children (SRC) physicians found.

Researchers at UT Southwestern Medical Center have developed a computational method that reveals how immune cells navigate the complex environment inside tumors, offering insights that could inform future cancer therapies.